The latest news & stories from the Providence Research Network

  • New report highlights the breadth & impact of research at Providence

    New report highlights the breadth & impact of research at Providence

    Providence researchers conducted over 1500 studies in 2025, according to a new report from the Providence Research Network. Check out the 2025 research program brief to learn more!

    Read Article
  • VOICES of Black Women: A community study in cancer prevention and care

    VOICES of Black Women: A community study in cancer prevention and care

    A new study focused on stories will change health outcomes for Black women.

    Read Article
  • Pioneering immunotherapy clinical trial enrolling patients with advanced cancers

    Pioneering immunotherapy clinical trial enrolling patients with advanced cancers

    A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.

    Read Article
  • CORE examines methods to boost participation in cancer genetic testing

    CORE examines methods to boost participation in cancer genetic testing

    New research from CORE and Providence Genomics asks whether how and where genetic testing is offered affects whether patients say “yes.”

    Read Article
  • Leading the way: Providence researchers at AACR Annual Meeting

    Leading the way: Providence researchers at AACR Annual Meeting

    The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

    Read Article
  • Providence Saint John’s Health Center Announces Largest Philanthropic Gift in Its History Through Transformative Stan Lucas Legacy

    Providence Saint John’s Health Center Announces Largest Philanthropic Gift in Its History Through Transformative Stan Lucas Legacy

    Read Article
  • Gene therapy shows promising results against multiple myeloma

    Gene therapy shows promising results against multiple myeloma

    This study is now enrolling patients at Providence Cancer Institute – the only site outside of Australia.

    Read Article
  • Treatment options, time, and hope for one family's "chief memory maker"

    Treatment options, time, and hope for one family's "chief memory maker"

    After Virginia Kuo was diagnosed with lung cancer, Providence Swedish experts were committed to helping this mom of three have the life she envisioned with her husband and family. Learn more

    Read Article
  • In groundbreaking heart valve trial, Providence Swedish is recognized as a global leader

    In groundbreaking heart valve trial, Providence Swedish is recognized as a global leader

    The MR Repair trial ranks Providence Swedish's echocardiography lab as a top-performing site for the advancement of mitral valve care. Learn more.

    Read Article
  • Providence Montana - HealthBreak - RESOLVE1:31

    Providence Montana - HealthBreak - RESOLVE

    Providence Montana - HealthBreak - RESOLVE RESOLVE is the name of a new collaborative between Providence Health, Providence St. Patrick Hospital, and the University of Montana aimed at improving heal

    Watch Video
  • Providence research in the news: cancer research equity toolkit featured in Becker's Oncology

    Providence research in the news: cancer research equity toolkit featured in Becker's Oncology

    A recent Beckers Health interview with Providence researcher Kristi Roybal, PhD, showcases the launch of an interactive toolkit to help health systems boost equity in medical research.

    Read Article
  • Using real-world data to inform next-generation nursing

    Using real-world data to inform next-generation nursing

    Learn how Providence researchers are providing valuable real-world data on the transition to next-generation nursing models.

    Read Article
  • Providence receives Pfizer-funded Conquer Cancer grant to use revolutionary AI tool to predict cancer mutations

    Providence receives Pfizer-funded Conquer Cancer grant to use revolutionary AI tool to predict cancer mutations

    Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients

    Read Article
  •  Providence Institute for Clinical Innovation shares how innovation impacts patients

    Providence Institute for Clinical Innovation shares how innovation impacts patients

    Read Article
  • CORE's 2025 annual report

    CORE's 2025 annual report

    CORE's 2025 Annual Report showcases how CORE and its cross-sector partners are working to advance health and health equity across the Western U.S. and beyond.

    Read Article
  • Providence researchers receive grant to explore new frontier of precision oncology

    Providence researchers receive grant to explore new frontier of precision oncology

    A generous grant from the Kuni Foundation is helping Providence researchers better understand lung cancer symptoms and improve patients' quality of life.

    Read Article
  • Clinical trial seeks better first-line therapy for follicular lymphoma

    Clinical trial seeks better first-line therapy for follicular lymphoma

    The study may redefine care for many people at the earliest stage of their treatment.

    Read Article
  • Where curiosity meets impact: Women in science at Providence Cancer Institute

    Where curiosity meets impact: Women in science at Providence Cancer Institute

    Get to know the women of the Immune Monitoring Laboratory and how their curiosity, tenacity and passion are driving progress in cancer research at Providence Cancer Institute.

    Read Article
  • Growing Providence’s research impact in West Texas with Covenant Health

    Growing Providence’s research impact in West Texas with Covenant Health

    2025 marked several exciting milestones for our efforts to expand access to cancer and stroke research in West Texas through Covenant Health

    Read Article
  • Providence St. Jude Oncologist Contributes to Breakthrough Study in Nature Medicine

    Providence St. Jude Oncologist Contributes to Breakthrough Study in Nature Medicine

    A major new study published in the prestigious journal Nature Medicine is offering renewed hope for cancer patients whose disease no longer responds to immunotherapy, and Providence St. Jude is proud

    Read Article
  • loading
    Loading More...